NuScale Power (SMR) Financials

Here’s a concise, investor-focused read on NuScale Power (NYSE: SMR) using the last four years of quarterly statements provided. The company remains in a cash-burn, development-stage phase, with meaningful liquidity now driven by financing activity even as operating performance remains loss-making.

• Large equity fundraising in 2025: NuScale completed a substantial issuance of common equity in Q4 2025, adding about $737 million of cash and boosting total equity to roughly $828 million (vs. about $693 million in Q2 2025). This strongly improved liquidity and reduces near-term dilution risk for current holders.
• Strong net financing inflows in late 2025 support liquidity: Net cash from financing activities was a major positive contributor in Q3 and Q4 2025 (approximately $463.8 million in Q3 and $737.5 million in Q4), helping offset large operating cash outflows.
• Asset and equity growth tied to financing activity: Total equity rose from roughly $693 million (Q2 2025) to about $829 million (Q3 2025), with continued equity-backed funding contributing to a stronger balance sheet headroom for ongoing development efforts.
• Investment sales contributing to cash receipts: The company recognized meaningful cash inflows from the sale/maturity of investments (e.g., about $126.8 million in Q3 2025 and $109.3 million in Q4 2025), aiding liquidity during higher expense periods.
• Cash balance and liquidity in mid-2025 showed materiality: For example, cash and equivalents were substantial in mid-2025 (e.g., around $407.6 million in Q3 2025), providing a cushion for ongoing R&D and capex as a pre-revenue company.
• Revenue remains volatile across quarters and years: Net sales moved from multi-digit millions in 2023–2024 to a mixed, smaller quarterly cadence in 2025 (e.g., around $8 million to $18 million in several 2025 quarters, with a spike in a later period). This volatility reflects project timing and contracting dynamics typical for a utility-scale, nuclear-development business.
• Persistent net losses across periods: Net income consistently negative across Q1–Q4 2025 and prior years, reflecting high development costs, ongoing operating expenses, and the absence of large industry-scale product revenue yet.
• Heavy operating cash outflows persist: Net cash from continuing operating activities was negative in every 2025 quarter (e.g., about -$22.8M in Q1, -$333.7M in Q2, -$199.8M in Q3, and -$203.7M in Q4), underscoring the ongoing burn before revenue scale is achieved.
• Large operating expenses relative to revenue in several quarters: SG&A and R&D expenses remained sizable (for example, combined annualized quarterly expenses often in the tens of millions), contributing to ongoing operating losses even when revenue improved in limited bursts.
• Balance-sheet leverage remains modest but recovery-dependent on financing: While cash and equity-funded liquidity has boosted the balance sheet, the company still carries meaningful liabilities and negative retained earnings in several periods, highlighting continued need for capital markets support and/or project milestones to progress toward profitability.

Bottom line for retail investors: NuScale’s path hinges on securing additional development milestones and translating them into revenue while managing operating costs. The company currently funds this gap primarily through equity financing and asset sales, which boosts liquidity but does not yet offset ongoing losses from operations. Investors should watch for follow-on financing plans, project progress, and any announced commercialization milestones that could materially affect revenue visibility and cashflow from operations.